Selective determination of ertapenem and imipenem in the presence of their degradants

Journal of Chromatographic Science

Volumn 48, Issue 8, 2010, Pages 624-630

  Abdel Moety, Ezzat M ^a   Elragehy, Nariman A ^a   Hassan, Nagiba Y ^a   Rezk, Mamdouh R ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957993084     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/48.8.624     Document Type: Article

References (42)

1. J. L. McGuire. Antinfectives, Endocrine and Metabolic Drugs; in: Pharmaceuticals Classes, Therapeutic Agents, Area of Application, Wiley-VCH Verlag, Weinheim, Germany, 2000, p. 952.
2. M J O'Neil (Ed), The Merck Index, 14th ed Merck & Co, Inc, Whitehouse Station, New Jersey, 2006, pp. 629.
3. The United States Pharmacopeia (USP 30), National Formulary (NF25), The United States Pharmacopeial Convention, Inc., Rockville (2007), pp. 2334-2336
4. J. Kohler, K. L. Dorso, K. Young, G. G. Hammond, H. Rosen, H. Kropp, and L. Silver. In Vitro Activities of the Potent, Broad-Spectrum Carbapenem MK-0826 (L-749, 345) against Broad-Spectrum β-Lactamase-and Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae and Escherichia coli Clinical Isolates. Antimicrob. Agents Chemother. 43:1170 (1999).
5. R. Mendez, T. Alemany, and J. Martin-Villacorta. Stability of the penems SCH 29482 and FCE 22101 in aqueous solution. Chem. Pharm. Bull. 40:2044 (1992)
6. Y. Takeuch, T. Inoue, and M. Sunagawa. Studies on the structures of meropenem (SM-7338) and it's primary metabolite J. Antibiot. 46:827 (1993)
7. R. W. Ratcliffe, K. J Wildonger, L. D. Michele, A. W. Douglas, R. Hajdu, R. T. Goegelman, J. P. Springer, and J. Hirshfield. Studies on the structure of imipenem, dehydropeptidase I hydrolyzed imipenem and related analogues J. Org. Chem. 54:653 (1989)
8. R. Mendez, T. Alemany, and J. Martin-Villacorta. Catalytic effect of buffers on degradation of imipenem (N-formimidoylthienamycin) in aqueous solutions Chem. Pharm. Bull. 39:831 (1991)
9. Y. Takeuchi, M. Sunagawa, Y. Hamazume, and T. Noguchi. Stability of a 1 β-methylcarbapenem antibiotic, meropenem in aqueous solution. Chem. Pharm. Bull. 43:689 (1995)
10. G. B. Smith, G. C. Dezeny, and A. W. Douglas. Stability and kinetics of degradation of imipenem in aqueous solution J. Pharm Sci. 79:732 (1990).
11. D. G. Musson, K. L. Birk, C. J. Kitchen, J. Zhang, J. Y. K. Hsieh, W. Fang, A. K. Majumdar, and J. D. Rogers. Assay methodology for the quantification of unbound ertapenem a new carbapenem antibiotic in human plasma J. Chromatogr. B 783:1 (2003)
12. J. B. Gordien, E. Boselli, C. Fleureau, B. Allaouchiche, G. Janvier, O. Lalaude, M. C. Sau, x and D. Breilh. Determination of free ertapenem in plasma and bronchoalveolar lavage by high-performance liquid chromatography with ultraviolet detection J. Chromatogr. B 830:218 (2006)
13. R. G. Mundkowski, J. M. Peszynska, O. Burkhardt, T. Welte, and B. Drewelow. A new simple HPLC assay for the quantification of ertapenem in human plasma, lung tissues, and broncho-alveolar lavage fluid. J. Chromatogr. B 832:231 (2006)
14. T. Koal, M. Deters, K. Resch, and V. Kaever. Quantification of the carbapenem antibiotic ertapenem in human plasma by a validated liquid chromatography-mass spectrometry method. Clin. Chim. Acta 364:239 (2006)
15. M. Soltani, A. P. MacGowan, and A. M. Lovering. Assay of ertapenem in human serum by high-performance liquid chromatography. Int. J. Antimicrob. Agents 27:165 (2006)
16. D. G. Musson, C. J. Kitchen, H. J. Y. K. Sieh, and K. L. Birk. Modified high-performance liquid chromatographic method for the determination of ertapenem in human urine: enhanced selectivity and automation. J. Chromatogr. B 779:341 (2002).
17. C. J. Kitchen, D. G. Musson, and A. L. Fisher. Column-switching technique for the sensitive determination of ertapenem in human cerebrospinal fluid using liquid chromatography and ultraviolet absorbance detection. J. Chromatogr. B 799:9 (2004).
18. A. Vailaya, P. Sajonz, O. Sudah, V. Capodanno, R. Helmy, and F. D. Antia. Exploiting pH mismatch in preparative high-performance liquid chromatographic recovery of ertapenem from mother liquor streams. J. Chromatogr. A 1079:80 (2005).
19. P. Sajonz, A. Vailaya, O. Sudah, L. McPherson, V. Capodanno, T. K. Natishan, R. Helmy, and F. D. Anita. Development of a gradient elution preparative high performance liquid chromatography method for the recovery of the antibiotic ertapenem from crystallization process streams. J. Chromatogr. A 1126:365 (2006).
20. P. Sajonz, T. K. Natishan, Y. Wu, J. M. Williams, B. Pipik, L. DiMichele, T. Novak, S. Pitzenberger, D. Dubost, and O. Almarsson. Preparation, isolation and characterization of dimeric degradation products of the 1 β-methylcarbapenem antibiotic, ertapenem. J. Liq. Chromatogr. Relat. Technol. 24:2999 (2001).
21. M. Zajac, J. Cielecka-Piontek, and A. Jelinska. Development and validation of UV spectrophotometric and RP-HPLC methods for determination of ertapenem during stability studies. Chem. Anal. 51:761 (2006).
22. M. Zajac, J. Cielecka-Piontek, and A. Jelinska. Stability of ertapenem in aqueous solutions. J. Pharm. Biomed. Anal. 43:445 (2007).
23. M. S. McQuade, V. V. Nostrand, J. Schariter, J. D. Kanike, and R. J. Forsyth. Stability and compatibility of reconstituted ertapenem with commonly used i.v. infusion and coinfusion solutions. Am. J. Health Syst. Pharm. 61:38 (2004).
24. CM. Myers and J. L. Blumer. Determination of imipenem and cilastatin in serum by high-performance liquid chromatography. Antimicrob. Agents Chemother. 26:78 (1984).
25. D. A. Gravallese, D. G. Musson, L. T. Pauliukonis, and W. F. Bayne. Determination of imipenem in human plasma and urine by highperformance liquid chromatography, comparison with microbiological methodology and stability. J. Chromatogr. Biomed. Appl. 310:71 (1984).
26. A. M. Bloh and J. M. Campos. Determination of N-formimidoylthienamycin concentration in sera from pediatric patients by highperformance liquid chromatography. J. Chromatogr. 375:444 (1986).
27. R. Krausse and U. Ullmann. Determination of imipenem and cilastatin in serum and tissue by high-performance liquid chromatography. Infection 14:243 (1986).
28. G. Carlucci, L. Biordi, C. Vicentini, and M. Bologna. Determination of imipenem in human plasma, urine and tissue by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 8:283 (1990).
29. D. G. Musson, R. Hajdu, W. F. Bayne, and J. D. Rogers. Quantification of imipenem primary metabolite in plasma by postcolumn chemical rearrangement and UV detection. Pharmaceut Res. 8:33 (1991).
30. L. Garcia-Capdevila, C. Lopez-Calull, C. Arroyo, M. A. Moral, M. A. Mangues, and J. Bonal. Determination of imipenem in plasma by high-performance liquid chromatography for pharmacokinetic studies in patients. J. Chromatogr. B 692:127 (1997).
31. J. A. Orsini, P. J. Moate, R. C. Boston, T. Norman, J. Engiles, C. E. Benson, and R. Poppenga. Pharmacokinetics of imipenemcilastatin following intravenous administration in healthy adult horses. J. Vet. Pharmacol. Therap. 28:355 (2005).
32. I. Aparicio, M. A. Bello, M. Callejon, and J. C. Jimenez. Liquid chromatographic method for the simultaneous determination of imipenem and sulbactam in mouse plasma. J. Chromatogr. Sci. 44:548 (2006).
33. I. Baranowska, P. Markowski, and J. Baranowski. Simultaneous determination of 11 drugs belonging to four different groups in human urine samples by reversed-phase high performance liquid chromatography method. Anal. Chem. Acta 570:46 (2006).
34. T. Niwa, A. Nakamura, T. Kato, T. Kutsuna, K. Katou, H. Morita, Y. Kojima, and M. Itoh. Pharmacokinetic study of pleural fluid penetration of carbapenem antibiotic agents in chemical pleurisy. Respir. Med. 100:324 (2006).
35. K. J. V Lopez, D. F. Bertoluci, K. M. Vicente, A. M. dell Aquilla, and S. R. C. Jorge Santos. Simultaneous determination of cefepim, vancomycin and imipenem in human plasma of burn patient by highperformance liquid chromatography. J. Chromatogr. B 860:241 (2007).
36. R. Fernandez-Torres, M. A. Bello-Lopez, M. Callejon-Mochon, and J. C. Jimenez-Sanchez. Determination of imipenem and rifampicin in mouse plasma by high performance liquid chromatographydiode array detection. Anal. Chem. Acta 608:204 (2008).
37. Y Kurihara, J. Kizu, and S. Hori. Simple and rapid determination of serum carbapenem concentrations by high-performance liquid chromatography. J. Infect. Chemother. 14:30 (2008).
38. J. Knoller, W. Konig, W. Schonfeld, K. D. Bremm, and M. koller. Application of high performance liquid chromatography of some antibiotics in clinical microbiology. J. Chromatogr. 427:257 (1988).
39. G. B. Smith, G. C. Dezeny and A. W. Douglas. Stability and kinetics of degradation of imipenem in aqueous solution. J. Pharm. Sci. 79:732 (1990).
40. M. R. Spiegel and L. J. Stephens (Eds.), Schaum outline of theory and problems of statistics, Schaum Outline Series, New York, 1999
41. A. R. Martin. Antibacterial Antibiotics in Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry, Delgado J. N. and Remers W. A. (Eds.), 10th ed., Lippencott-Raven, New York, 1998, pp. 253-280.
42. N. A. Elragehy, E. M. Abdel-Moety, N. Y Hassan, and M. R. Rezk. Stability-indicating determination of meropenem in presence of its degradation product. Talanta 77:28 (2008).